This company listing is no longer active
BIOS Stock Overview
Develops and sells wearable muscle strengthening systems worldwide.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Bioservo Technologies AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 0.016 |
52 Week High | SEK 2.39 |
52 Week Low | SEK 0.011 |
Beta | 0.80 |
11 Month Change | -33.33% |
3 Month Change | -96.30% |
1 Year Change | -99.15% |
33 Year Change | -99.90% |
5 Year Change | -99.83% |
Change since IPO | -99.92% |
Recent News & Updates
Shareholder Returns
BIOS | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | -14.9% | 0.3% | -0.4% |
1Y | -99.2% | -1.6% | 12.9% |
Return vs Industry: BIOS underperformed the Swedish Medical Equipment industry which returned -2.2% over the past year.
Return vs Market: BIOS underperformed the Swedish Market which returned 1.5% over the past year.
Price Volatility
BIOS volatility | |
---|---|
BIOS Average Weekly Movement | 31.2% |
Medical Equipment Industry Average Movement | 7.0% |
Market Average Movement | 5.9% |
10% most volatile stocks in SE Market | 12.3% |
10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: BIOS's share price has been volatile over the past 3 months.
Volatility Over Time: BIOS's weekly volatility has increased from 19% to 31% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 20 | Petter Backgren | www.bioservo.com |
Bioservo Technologies AB (publ) develops and sells wearable muscle strengthening systems worldwide. The company offers Ironhand, a robotic grip that strengthens gloves; and Carbonhand, a revolutionary assistive device for people with impaired hand function. Its products have applications in foundry, logistics, warehousing, and construction sectors, as well as used in pre-assembly and assembly tasks.
Bioservo Technologies AB (publ) Fundamentals Summary
BIOS fundamental statistics | |
---|---|
Market cap | SEK 1.36m |
Earnings (TTM) | -SEK 46.93m |
Revenue (TTM) | SEK 11.86m |
0.1x
P/S Ratio0.0x
P/E RatioIs BIOS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BIOS income statement (TTM) | |
---|---|
Revenue | SEK 11.86m |
Cost of Revenue | SEK 10.28m |
Gross Profit | SEK 1.58m |
Other Expenses | SEK 48.51m |
Earnings | -SEK 46.93m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 20, 2024
Earnings per share (EPS) | -0.55 |
Gross Margin | 13.30% |
Net Profit Margin | -395.68% |
Debt/Equity Ratio | 0% |
How did BIOS perform over the long term?
See historical performance and comparison